for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Getein Biotech Inc

603387.SS

Latest Trade

22.68CNY

Change

-0.10(-0.44%)

Volume

687,510

Today's Range

22.60

 - 

22.85

52 Week Range

18.24

 - 

33.84

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
22.78
Open
22.78
Volume
687,510
3M AVG Volume
69.84
Today's High
22.85
Today's Low
22.60
52 Week High
33.84
52 Week Low
18.24
Shares Out (MIL)
260.38
Market Cap (MIL)
5,931.46
Forward P/E
--
Dividend (Yield %)
1.29

Latest Developments

More

Getein Biotech's Shareholders To Unload Up To 6 Percent Stake During Mar 6-Sep 2

Getein Biotech's Shareholder To Unload Up To 2.45 Pct Stake Within Six Months

Getein Biotech's Four Shareholders Plan To Unload Up To 9 Pct Stake Within Six Months

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Getein Biotech Inc

Getein Biotech, Inc. is a China-based company principally engaged in the research and development, production and sales of in vitro diagnostic products. The Company's main products include point-of-care testing (POCT) in vitro diagnostic reagents and ancillary equipment. The Company is also engaged in the production and sales of biochemical latex in vitro diagnostic reagents. The Company mainly operates its businesses in East China, Central China, North China and Southwest region.

Industry

Biotechnology & Drugs

Contact Info

+86.25.68568577

http://www.bio-gp.com.cn/

Executive Leadership

Enben Su

Chairman of the Board, General Manager

Wen Ni

Chief Financial Officer

Binbin Yan

Deputy General Manager, Secretary of the Board, Director

Bin Li

Director

Enkui Su

Director

Key Stats

Price To Earnings (TTM)
22.31
Price To Sales (TTM)
6.87
Price To Book (MRQ)
3.97
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
1.39
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
19.88
Return on Equity (TTM)
17.35

Latest News

Latest News

BRIEF-Getein Biotech to set up biotech JVs in Xinjiang and Harbin

* Says it plans to invest 15.3 million yuan to set up a Xinjiang-based biotech JV with partner, with registered capital of 30 million yuan

BRIEF-Getein Biotech says 2017 dividend payment

* Says it plans to pay cash dividend of 4.5 yuan per 10 shares (before tax) and use additional paid-in capital to distribute 4 new shares for every 10 shares to shareholders for 2017

BRIEF-Getein Biotech unit obtains high-tech enterprise recognition and to enjoy tax preference

* Says its unit was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years

BRIEF-Getein Biotech unit to buy pharma tech firm for 3 mln yuan

* Says its Jilin-based controlling bio-tech unit plans to buy 100 percent stake in a Changchun-based pharma tech company for 3 million yuan

BRIEF-Getein Biotech elects chairman

Getein Biotech Inc * Says board elects Su Enben as chairman Source text in Chinese: http://bit.ly/2zPVC0F Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Getein Biotech to invest 20 mln yuan to set up medical examination unit in Nanjing

* Says it will invest 20 million yuan to set up a wholly owned medical examination unit in Nanjing

BRIEF-Getein Biotech adopts new accounting policy regarding subsidy

* Says it adopted new accounting policy regarding subsidy, effective since June 12

BRIEF-Getein Biotech to set up bio-tech unit in Hubei

* Says it plans to set up a wholly owned bio-tech subsidiary in Hubei, with registered capital of 10 million yuan

BRIEF-Getein Biotech to invest 10 mln yuan to set up Sichuan-based biotechnology firm

* Says it will invest 10 million yuan to set up a wholly owned Sichuan-based biotechnology firm to improve marketing capabilities in the Southwest

BRIEF-Online part of Getein Biotech's Shanghai IPO oversubscribed

* Getein biotech says online part of shanghai ipo attracted interest amounting to 3,420.2 times amount on offer

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up